NanoLogix and Saudi Company To Work Together for Distribution of NanoLogix Products in the Arabian Gulf Region
December 04 2013 - 12:02AM
Business Wire
Announces additional product offerings with
E-Beam sterilization process
NanoLogix, Inc. (NNLX), an innovator in the rapid detection,
identification of live bacteria, and determination of their
antibiotic resistance and sensitivity, announces that they are
working with Nasaem-Aljazira, a Saudi Arabian company headquartered
in Riyadh, to establish exclusive distribution and/or manufacturing
of NanoLogix products in Saudi Arabia and the Arabian Gulf region,
also known as the Gulf Cooperation Council (GCC) area.
This area offers a large market potential to Nasaem-Aljazira and
NanoLogix, with Saudi Arabia being a leader in advanced health care
initiatives for its people.
NanoLogix is also in negotiations with groups and companies in
Europe, Asia and Africa on additional distribution outlets and
manufacturing options.
The Company currently sells and ships its products in the US and
to the UK.
In keeping with NanoLogix’ policy of continual product
improvement, the Company has begun electron beam (e-Beam)
processing of the majority of its filled Petri plate and BNP
detection kit FlatPacks through the facilities at Synergy
HealthAST.
http://www.synergyhealthplc.com/us/applied-sterilization-technologies/electron-beam
This process was initiated to ensure that our FlatPack preserved
Petri plates and BNP kits remain viable throughout their extended
shelf life, which in some cases for common agars have now exceeded
one year at room temperature and two years in cold storage. These
times are in sharp contrast with the 3-4 months of shelf life
available with competitor’s products and offer a significant
economic advantage to customers with limited or no cold storage
capacity, or those with dynamic testing and project schedules.
NanoLogix recently added 13 additional product variants that
have been in demand by its customers and has improved its ordering
procedure, enabling a “mix and match” capability for ordering that
allows customers to order up to ten different Flatpack detection
products in one single carton.
http://nanologix.com/products/TSA2.php
NanoLogix and researchers at UTHSC Houston are working to
finalize development of the Company’s new N-Assay detection and
identification assay. The original concept for use with one
bacteria has expanded to one in which as many as five different
pathogens can be rapidly detected, identified, and analyzed for
antibiotic sensitivity or resistance on one N-Assay multiwell
microplate.
About NanoLogix, Inc.
NanoLogix is a biotechnology company focused primarily on rapid
diagnostics. Its products offer accelerated detection and
identification of microorganisms. In addition to medical, National
Defense, and homeland security applications, NanoLogix technology
is applicable in pharmaceutical, industrial, veterinary and
environmental testing.
Patents granted to NanoLogix can be used in the areas of applied
microbiology, soil microbiology and bioremediation, microbial
physiology, molecular biology, pharmacology, pharmaco-kinetics, and
antibiotic sensitivity
For more information visit www.nanologix.com.
This press release contains statements, which may constitute
"forward- looking statements" within the meaning of the Securities
Act of 1933 and the Securities Exchange Act of 1934, as amended by
the Private Securities Litigation Reform Act of 1995. Those
statements include statements regarding the intent, belief or
current expectations of NanoLogix, Inc., and members of its
management as well as the assumptions on which such statements are
based. Prospective investors are cautioned that any such
forward-looking statements are not guarantees of future performance
and involve risks and uncertainties, and that actual results may
differ materially from those contemplated by such forward-looking
statements. The Company undertakes no obligation to update or
revise forward-looking statements to reflect changed assumptions,
the occurrence of unanticipated events or changes to future
operating results.
NanoLogix, Inc.Investors:Carol Surrena,
330-534-0800carol@nanologix.com
NanoLogix (CE) (USOTC:NNLX)
Historical Stock Chart
From Nov 2024 to Dec 2024
NanoLogix (CE) (USOTC:NNLX)
Historical Stock Chart
From Dec 2023 to Dec 2024